Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
07/2012
07/05/2012WO2012092053A1 Bovine viral diarrhea virus type 1b vaccine compositions and methods
07/05/2012WO2012091718A1 Polymalic acid-based nanobiopolymer compositions and methods for treating cancer
07/05/2012WO2012091564A2 A cross-linking polypeptide that induces apoptosis
07/05/2012WO2012091118A1 Therapeutic agent for ectopic pregnancy
07/05/2012WO2012090939A1 Method for suppressing receptor tyrosine kinase-mediated prosurvival signaling in cancer cells
07/05/2012WO2012090895A1 Monoclonal antibody capable of recognizing human papilloma virus (hpv) l2 protein, and method for measuring hpv-neutralizing antibody titer using same
07/05/2012WO2012090104A1 Methods and compositions for designing novel conjugate therapeutics
07/05/2012WO2012090002A1 Fluorocarbon-linked peptide formulation
07/05/2012WO2012090000A1 Inactivated poliovaccine
07/05/2012WO2012089833A2 Expression Systems
07/05/2012WO2012089800A1 Immunostimulatory oligodeoxynucleotides
07/05/2012WO2012089778A1 Pharmaceutical formulation comprising a biopharmaceutical drug
07/05/2012WO2012089749A1 Salmonid alphavirus protein e2
07/05/2012WO2012089748A1 Canine babesiosis vaccine antigen
07/05/2012WO2012089742A2 IDENTIFICATION OF A NOVEL HUMAN POLYOMAVIRUS (IPPyV) AND APPLICATIONS
07/05/2012WO2012089338A1 Combination of vaccination and inhibition of mhc class restricted antigen presentation
07/05/2012WO2012089231A1 Paramyxovirus vaccines
07/05/2012WO2012089225A1 Combination of vaccination and inhibition of mhc class i restricted antigen presentation
07/05/2012WO2012088763A1 Hepatitis a virus strain sh and method for adapting same to diploid cells
07/05/2012WO2012088739A1 Method for preparing fusion protein of mycobacterium tuberculosis antigens and uses thereof
07/05/2012WO2012088605A1 Roadmap for controlling malaria
07/05/2012WO2012088563A1 Vegfr-2-specific forms of vegf-d and vegf-c and uses thereof
07/05/2012WO2012064967A3 Cancer cell-derived receptor activator of the nf-kb ligand drives bone and soft tissue metastases
07/05/2012WO2012064836A9 Methods and compositions for neural disease immunotherapy
07/05/2012WO2012059928A3 Antivenom
07/05/2012WO2012054564A3 Anti-vegf antibody/fragment conjugated gold nanoparticles, and fabrication and therapeutic methods
07/05/2012WO2012048125A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl trna synthetases
07/05/2012WO2012047724A4 Antibody drug conjugates (adc) that bind to 191p4d12 proteins
07/05/2012WO2012028622A3 Peptide or peptide complex binding to 2 integrin and methods and uses involving the same
07/05/2012WO2012024223A3 Compositions and methods of use comprising combinations of anti-cd74 antibodies with a therapeutic agent. the therapeutic agent may be attached to the anti-cd74 antibody or may be separately administered, either before, simultaneously with or after the anti-cd74 antibody
07/05/2012WO2012021730A3 Respiratory syncytial virus (rsv) vaccine
07/05/2012WO2012021475A3 ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
07/05/2012WO2012018813A3 Modified infectious laryngotracheitis virus (iltv) and uses thereof
07/05/2012WO2012006380A3 Cationic oil-in-water emulsions
07/05/2012WO2012006377A3 Methods of raising an immune response by delivery of rna
07/05/2012WO2012003129A3 Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host
07/05/2012WO2011163478A4 Dual variable domain immunoglobulins and uses thereof
07/05/2012WO2011153250A3 Crosslinking of proteins and other entities via conjugates of alpha-haloacetophenones, benzyl halides, quinones, and their derivatives
07/05/2012WO2011110953A3 Polyepitope constructs and methods for their preparation and use
07/05/2012WO2011110642A3 Monoclonal antibodies against c-met
07/05/2012WO2011084366A3 Compositions and drug delivery systems for intraocular delivery of sirna molecules, their use for treating conditions
07/05/2012WO2011069019A3 J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen
07/05/2012WO2010111687A3 Methods and compositions for immunization against virus
07/05/2012WO2010036460A3 Anti-cd147 antibodies, methods, and uses
07/05/2012US20120174243 SOGA Polynucleotides and Polypeptides and Uses Thereof
07/05/2012US20120171292 Luminescent porous silicon nanoparticles for targeted delivery and immunization
07/05/2012US20120171290 Hpv particles and uses thereof
07/05/2012US20120171289 Delivery systems for bioactive agents
07/05/2012US20120171256 Electrospun silk material systems for wound healing
07/05/2012US20120171251 Sheet-form preparation and method for producing the same
07/05/2012US20120171248 Compounds and methods for immunotherapy and diagnosis of tuberculosis
07/05/2012US20120171247 Novel proteins within the type e botulinum neurotoxin complex
07/05/2012US20120171246 Immunization to reduce neurotoxicity during treatment with cytolytic viruses
07/05/2012US20120171245 Inhibitors of influenza viruses replication
07/05/2012US20120171244 Mucosal boosting following parenteral priming
07/05/2012US20120171243 Method of preparing live viral vaccines by genetic engineering of viral genome
07/05/2012US20120171242 Modified Antibody
07/05/2012US20120171241 Analysis of saccharide vaccines without interference
07/05/2012US20120171240 Immunostimulatory compositions and methods
07/05/2012US20120171239 Immunogenic Conjugates for Producing Immune Responses to Drugs of Abuse and Methods of Use
07/05/2012US20120171238 S. aureus allergen
07/05/2012US20120171237 Recombinant chimeric antigens for diagnosis and prevention of scrub typhus
07/05/2012US20120171236 Immunization against chlamydia pneumoniae
07/05/2012US20120171235 Markers of xmrv infection and uses thereof
07/05/2012US20120171234 Novel Biologically Active Peptides and their New Uses
07/05/2012US20120171233 Peptide inhibitors for mediating stress responses
07/05/2012US20120171232 In vivo efficacy of ny-eso-1 plus adjuvant
07/05/2012US20120171231 Use of nutritional compositions including lactoferrin in stimulating immune cells
07/05/2012US20120171230 Oral vaccines produced and administered using edible micro-organism
07/05/2012US20120171229 Synthetic nanocarriers with reactive groups that release biologically active agents
07/05/2012US20120171228 Anti-cancer regimen
07/05/2012US20120171227 Pro-drug complexes and related methods of use
07/05/2012US20120171226 Antibodies to high molecular weight melanoma associated antigen
07/05/2012US20120171225 Diagnostic Method for Predicting the Risk of Cancer Recurrence Based on Histone Macroh2A Isoforms
07/05/2012US20120171224 Anti-ADDL Antibodies and Uses Thereof
07/05/2012US20120171223 High affinity antibodies that neutralize staphylococcus enterotoxin b
07/05/2012US20120171222 Methods and compositions involving nucleotide repeat disorders
07/05/2012US20120171221 Biomarkers for the early detection of autoimmune diseases
07/05/2012US20120171220 Further use of protein kinase n beta
07/05/2012US20120171219 Use of pkc-zeta as a breast cancer tumorigenic biomarker as well as a target for treatment of breast cancer
07/05/2012US20120171218 Compositions And Methods For The Therapy And Diagnosis Of Influenza
07/05/2012US20120171217 Monoclonal Antibodies Against ANGPTL4
07/05/2012US20120171216 Palmitated monoclonal antibody
07/05/2012US20120171215 Nogo-a binding molecules and pharmaceutical use thereof
07/05/2012US20120171214 Polypeptides
07/05/2012US20120171213 Method of treating tumors
07/05/2012US20120171212 Therapeutic compositions and methods for the prevention of autoimmune diseases
07/05/2012US20120171211 Serum resistance factors of gram positive bacteria
07/05/2012US20120171210 Methods and compositions for inhibiting c-met dimerization and activation
07/05/2012US20120171209 Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
07/05/2012US20120171208 Anti-PRO87299 Antibodies
07/05/2012US20120171207 Depleting immunosuppressive monocytes within a mammal
07/05/2012US20120171206 Methods of stimulating liver regeneration
07/05/2012US20120171205 Galectin-Immunoglobulin Chimeric Molecules
07/05/2012US20120171204 Compositions and methods for the treatment and diagnosis of immune disorders
07/05/2012US20120171203 Activin receptor-like kinase-1 compositions and methods of use
07/05/2012US20120171202 Rage Fusion Proteins And Methods Of Use
07/05/2012US20120171201 Methods of treating her2 positive cancer with her2 receptor antagonist in combination with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
07/05/2012US20120171200 Antibodies With Immune Effector Activity And That Internalize In Folate Receptor Alpha-Positive Cells
07/05/2012US20120171199 Tricyclic pi3k inhibitor compounds and methods of use
1 ... 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 ... 1823